Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M518Revenue $M0.8Net Margin (%)-2,495.1Altman Z-Score13.5
Enterprise Value $M466EPS $-2.7Operating Margin %-2,338.3Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-2,495.1Higher ROA y-yN
Price/Book9.810-y EBITDA Growth Rate %--Quick Ratio9.6Cash flow > EarningsN
Price/Sales2205-y EBITDA Growth Rate %--Current Ratio9.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-53.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-123.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with OCUL

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

OCUL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


OCUL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Polaris Venture Management Co.10% Owner 2015-02-02Sell500,000$29.5-18.07 view
SVLSF IV, LLC10% Owner 2014-07-30Buy715,380$1385.92 view
Sawhney AmarpreetPresident and CEO, 10% Owner 2014-07-30Buy76,922$1385.92 view
CHV II, L.P.10% Owner 2014-07-30Buy153,846$1385.92 view
Ankerud EricSee Remarks 2014-07-30Buy1,000$1385.92 view

Press Releases about OCUL :

    Quarterly/Annual Reports about OCUL:

    News about OCUL:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: APD, OCUL, CNMD, OPK, AEGR Aug 04 2014 

    More From Other Websites
    OCULAR THERAPEUTIX, INC Financials May 27 2015
    Ocular Therapeutix Inc Earnings Call scheduled for 8:00 am ET today May 15 2015
    Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of... May 15 2015
    Q1 2015 Ocular Therapeutix Inc Earnings Release - Time Not Supplied May 15 2015
    Ocular Therapeutix reports 1Q loss May 15 2015
    Ocular Therapeutix reports 1Q loss May 15 2015
    OCULAR THERAPEUTIX, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 15 2015
    Ocular TherapeutixTM Announces Plans to Proceed with an NDA Submission for OTX-DP for Treatment of... May 15 2015
    Analyst Issues 5 Potential Biotech Buyout Candidates May 14 2015
    Gilead Sciences, Inc. (GILD), Infoblox Inc (BLOX) Among David Lamond’s Top Healthcare and... May 13 2015
    Ocular Therapeutix™ to Report First Quarter 2015 Financial Results May 06 2015
    Ocular Therapeutix™ to Report First Quarter 2015 Financial Results May 06 2015
    Ocular Therapeutix to Present Eight Posters Highlighting its Sustained Release Hydrogel Platform... May 01 2015
    Ocular Therapeutix to Present Eight Posters Highlighting its Sustained Release Hydrogel Platform... May 01 2015
    Ocular Therapeutix (OCUL) in Focus: Stock Goes Down 6.4% - Tale of the Tape Apr 10 2015
    Ocular Therapeutix Slumps 19% after Negative Study Data - Analyst Blog Apr 08 2015
    What We’re Trading Apr 07 2015
    Early movers: JPM, FDX, INFA, VIAB, GM & more Apr 07 2015
    Clovis Cancer 'Breakthrough,' Oculus Flop Top Biotech News Late Apr 06 2015
    Ocular Therapeutix slumps on eye treatment study Apr 06 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK